Peptide manufacturers operating under Good Manufacturing Practice (GMP) standards with documented quality systems meeting FDA cGMP (21 CFR 210/211), EU GMP (EudraLex Volume 4), or PIC/S GMP requirements. GMP certification for peptide manufacturing requires validated facilities with environmental monitoring programs, equipment qualification (IQ/OQ/PQ), process validation with documented batch records, cleaning validation to prevent cross-contamination, supplier qualification programs for starting materials including amino acid derivatives and resins, stability testing programs per ICH Q1 guidelines, and a quality management system with change control, deviation investigation, and CAPA procedures. GMP-certified peptide manufacturers are subject to regulatory inspection by FDA, EMA, Swissmedic, PMDA, or other national authorities with inspection outcome directly affecting facility certification status. Bachem reports having received inspections from FDA, EMA, Swissmedic, PMDA, CDE (China), and ANVISA (Brazil) across its global manufacturing network. Showing 73 verified suppliers matching this quality standard.